U.S. Healthcare Services Stock News

NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

Assessing eXp World Holdings (EXPI) Valuation After Recent Share Price Weakness

Why eXp World Holdings (EXPI) is on investors’ radar Recent trading in eXp World Holdings (EXPI) has drawn attention after a stretch of weak returns, including declines over the past month, past 3 months and year, prompting closer scrutiny of the stock. See our latest analysis for eXp World Holdings. At a share price of $6.84, eXp World Holdings has seen a 23.23% 1 month share price decline and a 30.79% 1 year total shareholder return decline. This suggests momentum has been fading as...
NYSE:CAVA
NYSE:CAVAHospitality

Why CAVA Group (CAVA) Is Down 7.2% After Mixed 2025 Results And Aggressive Expansion Plans

CAVA Group, Inc. recently reported its fourth-quarter and full-year 2025 results, with sales rising to US$274.99 million for the quarter and US$1.18 billion for the year, while net income and earnings per share were lower than the prior year. Alongside these results, management outlined ambitious expansion plans and same-store sales growth targets, signaling a focus on scaling the restaurant footprint and driving comparable-restaurant performance. Next, we’ll examine how CAVA’s plan to open...
NYSE:BMI
NYSE:BMIElectronic

Assessing Badger Meter (BMI) Valuation After Recent Share Price Weakness

Recent performance snapshot Badger Meter (BMI) has recently drawn attention after a challenging stretch for the stock, with negative returns over the past month, past 3 months, year to date, and the past year, despite a positive 3 year and 5 year track record. See our latest analysis for Badger Meter. At a share price of US$149.11, Badger Meter has recently faced fading momentum, with a 16.1% 90 day share price return and a 28.5% 1 year total shareholder return both in decline, in contrast...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is Nasdaq’s (NDAQ) Binary Options Push a Strategic Test of Its Market-Quality Narrative?

Nasdaq, Inc. recently filed with the U.S. Securities and Exchange Commission to launch binary options and Outcome Related Options on the Nasdaq 100 and related indices, marking its move into SEC-regulated prediction-style markets. This planned expansion into yes-or-no, event-focused contracts could broaden Nasdaq’s derivatives ecosystem and deepen engagement across its technology-enabled trading and financial crime management platforms. We’ll now examine how Nasdaq’s push into...
NYSE:MRK
NYSE:MRKPharmaceuticals

Assessing Merck (MRK) Valuation As Recent Share Price Momentum Draws Fresh Attention

Why Merck (MRK) is Back on Investors’ Radar Merck (MRK) has caught investors’ attention after recent performance data showed a mix of short term pullbacks and longer term strength, prompting fresh interest in how its current valuation lines up with fundamentals. See our latest analysis for Merck. At a share price of US$120.28, Merck has paired a 30 day share price return of 6.1% with a 90 day gain of 19.22%. Its 1 year total shareholder return of 33.92% stands out against its longer term 5...
NYSE:WMB
NYSE:WMBOil and Gas

A Look At Williams Companies (WMB) Valuation After Strong Recent Share Price Momentum

Williams Companies stock update after recent price move Williams Companies (WMB) has been on many watchlists after a recent share move, with the stock closing at $75.77 as investors reassess its valuation and return profile. Over the past month, WMB has recorded a total return of 14.21%, and about 19.02% over the past 3 months. This has placed extra attention on how its current price lines up with its fundamentals. See our latest analysis for Williams Companies. That recent 14.21% 1 month...
NYSE:NYT
NYSE:NYTMedia

A Look At New York Times (NYT) Valuation After Broad Shelf Registration Filing

Why New York Times Filed a Broad Shelf Registration The New York Times (NYT) recently filed an omnibus shelf registration covering Class A common stock, preferred stock, debt securities, warrants, depositary shares, stock purchase contracts, and stock purchase units. This filing gives the company flexibility to access capital markets as needed. For you as an investor, this filing does not mean new securities will be issued immediately. It puts the framework in place if the company decides to...
NYSE:NUE
NYSE:NUEMetals and Mining

Is Nucor (NUE) Still Attractive After A 35% One Year Share Price Gain

If you are wondering whether Nucor's share price still reflects good value or is already pricing in a lot of optimism, you are in the right place. Nucor's stock closed at US$176.07, with returns of 0.3% over 7 days, a 2.7% decline over 30 days, 3.9% year to date and 35.1% over 1 year. The 5 year return stands at 182.1% and the 3 year return at 6.1%. Recent headlines around Nucor have mainly focused on its position in the US steel industry and how investors are thinking about its long term...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Is It Time To Reassess Akamai Technologies (AKAM) After Recent Share Price Strength?

If you are wondering whether Akamai Technologies at around US$102.98 is offering fair value right now, you are not alone; many investors are asking the same question. The stock has returned 2.9% over the last 7 days, 6.6% over the past month, 21.0% year to date and 24.3% over the last year, with a 38.4% return over 3 years and 6.9% over 5 years adding useful context for anyone thinking about their entry point. Recent coverage has focused on Akamai's position in content delivery and cloud...
NYSE:IOT
NYSE:IOTSoftware

Is Samsara (IOT) Now Attractive After Mixed Share Price Performance And DCF Upside?

If you are wondering whether Samsara's current share price lines up with its underlying business, this article walks through the key numbers so you can judge how the stock stacks up on value. The share price closed at US$28.69 most recently, with returns of 4.6% over the last 7 days, 8.6% over the last 30 days, a 15.4% decline year to date, and a 34.2% decline over the past year, compared with a 36.0% gain over the past 3 years. Recent coverage around Samsara has centred on its role in...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

How Gold Royalty’s (GROY) Expanded, Lower-Cost Credit Facility Has Changed Its Investment Story

Gold Royalty Corp. recently upsized and amended its credit facility to as much as US$150 million with a bank syndicate, securing a larger US$125 million revolving line, a US$25 million accordion feature, lower SOFR-linked interest margins, and an extended maturity to November 2028. Alongside this cheaper, expanded financing, the company reported record 2025 revenue and highlighted operational progress across multiple royalty and streaming assets, underlining how balance sheet flexibility and...
NYSE:NEE
NYSE:NEEElectric Utilities

NextEra Energy Equity Raise Targets Data Center Power Growth Story

NextEra Energy (NYSE:NEE) completed a $2.3b equity units offering, adding fresh capital to its balance sheet. The company outlined plans to add up to 30 gigawatts of new generation capacity by 2035. The planned build out is aimed at serving rising U.S. data center electricity demand. NextEra Energy, through its regulated utility and large renewables portfolio, sits at the center of U.S. power and infrastructure spending. The latest capital raise and capacity plan come as data centers...
NYSE:MOD
NYSE:MODBuilding

Modine Manufacturing (MOD) Is Down 8.8% After Strong Q3, Raised Guidance And Spin-Off Plan - Has The Bull Case Changed?

Modine Manufacturing recently reported stronger-than-expected Q3 FY2026 results, highlighted by robust data center segment performance, raised full-year guidance, and a plan to spin off its Performance Technologies segment to sharpen focus on core thermal management solutions. This combination of better earnings, a clearer focus on higher-growth thermal applications, and a dedicated data center growth target of US$2.00 billion by FY2028 could meaningfully reshape how investors view the...
NYSE:TRNO
NYSE:TRNOIndustrial REITs

Terreno Realty Expands Coastal Industrial Footprint With Leases And Acquisitions

Terreno Realty (NYSE:TRNO) reported significant leasing activity in California and two industrial property acquisitions in New York over the past two weeks. The company secured several full building leases in Los Angeles County, covering multiple properties. Terreno acquired a large cross dock distribution center in Queens and a redevelopment focused industrial asset in the Bronx, both near key transportation corridors. Terreno Realty focuses on industrial real estate in high demand U.S...
NYSE:RPM
NYSE:RPMChemicals

Assessing RPM International (RPM) Valuation After Mixed Recent Shareholder Returns

Why RPM International is on investors’ radar today RPM International (RPM) is drawing attention after recent trading left the stock around $108.87, with performance mixed across different timeframes, including a decline over the past year but gains over the past 3 months. See our latest analysis for RPM International. RPM’s recent share price softness, with a 7 day share price return of 4.68% and a 1 year total shareholder return decline of 10.81%, contrasts with positive 3 and 5 year total...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Why Skyward Specialty (SKWD) Is Up 6.0% After ESOP Shelf Filing And Strong Q4 Results

Skyward Specialty Insurance Group recently filed a US$41.71 million shelf registration for 858,647 common shares linked to its ESOP and reported fourth-quarter 2025 revenue of US$385.59 million with net income of US$43.23 million. These results, alongside insider share purchases and expanded specialty programs such as captives and agriculture & credit (re)insurance, highlight management’s confidence and a deeper push into higher-complexity, niche insurance lines. With this backdrop of strong...
NYSE:BAX
NYSE:BAXMedical Equipment

Reassessing Baxter International (BAX) Valuation After Recent Share Price Weakness

Why Baxter International (BAX) Is Back on Investors’ Radar Baxter International (BAX) has drawn fresh attention after its shares closed at $19.03, with mixed recent returns across the week, month, and past 3 months prompting investors to reassess the healthcare supplier. See our latest analysis for Baxter International. At a share price of $19.03, Baxter’s recent 7 day share price return of an 8.2% decline and year to date share price return of a 2.4% decline sit against a 1 year total...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Axcelis Technologies (ACLS) Valuation Check After Mixed Short And Long Term Share Price Performance

Axcelis Technologies stock: recent performance snapshot Axcelis Technologies (ACLS) has drawn attention after its recent trading performance, with the shares last closing at US$86.62 and showing mixed returns over the month, the past 3 months, and the past year. See our latest analysis for Axcelis Technologies. Recent momentum has been mixed, with a 7 day share price return of 3.6% and a 30 day share price return of 2.7%, set against a 90 day share price return decline of 4.6% and a 1 year...
NasdaqGS:LZ
NasdaqGS:LZProfessional Services

LegalZoom Claude AI Tie Up Prompts Fresh Look At Valuation

LegalZoom.com (NasdaqGS:LZ) is integrating its attorney-services platform into the Claude AI ecosystem. The move blends automated legal document analysis with access to LegalZoom’s network of attorneys without hourly billing or retainers. The integration is designed to support consumers and businesses dealing with complex compliance and liability questions. For LegalZoom, known for its online legal documents and access to attorneys, this step pushes its model further into AI supported...
NYSE:MPLX
NYSE:MPLXOil and Gas

MPLX Weighs Corporate Shift While Balancing Growth Projects And Buybacks

MPLX (NYSE:MPLX) is weighing a shift from its current master limited partnership structure to a traditional corporation. The company is pairing this review with continued spending on growth projects and ongoing unit buybacks. Management is assessing how a potential conversion could affect valuation, income distributions, and the mix of unitholders and shareholders. MPLX operates in the midstream energy space, focusing on gathering, processing, and transportation assets that sit between...
NYSE:UNH
NYSE:UNHHealthcare

UnitedHealth Faces DOJ Scrutiny As Leadership Reset Targets Margin Recovery

UnitedHealth Group (NYSE:UNH) is under new US Department of Justice scrutiny over Medicare Advantage billing practices. The company is undergoing leadership changes, including the return of a former CEO, alongside executive and operational shifts. Management has announced layoffs and salary caps that limit pay increases for many employees. UnitedHealth is guiding for its first annual revenue decline since the 1980s. UnitedHealth Group sits at the center of US managed care and health...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron Expands AI Memory Capacity And India Footprint As Valuation Looms

Micron Technology (NasdaqGS:MU) has begun shipping a 256GB SOCAMM2 LPDRAM module, described as the industry's highest capacity low power DRAM for AI data centers. The company has opened a major semiconductor assembly and test facility in India, expanding its global manufacturing footprint. Micron is a key memory supplier for data centers, PCs, mobile devices and emerging AI workloads, so any move in its DRAM portfolio tends to draw attention from investors who follow infrastructure behind...
NasdaqGS:TFSL
NasdaqGS:TFSLBanks

Assessing TFS Financial (TFSL) Valuation After A Period Of Steady Returns

What recent returns suggest about TFS Financial (TFSL) TFS Financial (TFSL) has been relatively steady, with the share price near $14.24 and returns that include a modest 1 year total return of 21.28% and a 3 year total return of 35.2%. See our latest analysis for TFS Financial. Recent share price movement has been fairly muted, with the latest close at $14.24 and a modest year to date share price return of 4.94%, while longer term total shareholder returns over three and five years show a...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

SELLAS Life Sciences (SLS) Is Up 21.8% After REGAL Trial Clears Key Continuation Review - What's Changed

In recent months, SELLAS Life Sciences Group reported encouraging activity for SLS009 in combination with AZA/VEN in relapsed/refractory AML and confirmed that the Independent Data Monitoring Committee recommended the Phase 3 REGAL trial continue without modification, with final analysis expected before year-end. This combination of positive efficacy signals and trial continuity strengthens the clinical credibility of SELLAS’s pipeline in a difficult-to-treat leukemia setting. We’ll now...